Search - tctmd.com

Displaying 121 - 140 of 334

Sort: Relevancy | Date

Presentation TCT 2019

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

Presenter: Robert-Jan Van Geuns

September 25, 2019

Presentation ARCH 2019

Update: Drug-Eluting Stents

Presenter: Jeffrey W. Moses

April 12, 2019

Presentation ARCH 2019

Update on Dual Antiplatelet Therapy

Presenter: James B Hermiller

April 12, 2019

Presentation ARCH 2019

LAA Closure Patient Selection, Imaging and Anti-Thrombotic Therapy

Presenter: Steven J Yakubov

April 11, 2019

Presentation CIT 2019

Practical Considerations for Long DAPT Based on Lesion and Patient Selections

Presenter: Tullio Palmerini

March 28, 2019

Presentation SIF 2019

Pharmacologic Strategies for Managing Patients with Atrial Fibrillation Undergoing Coronary Intervention

Presenter: Michael A. Kutcher

March 28, 2019

Presentation SIF 2019

DAPT Duration and When to Switch to Antiplatelet Monotherapy Post PCI

Presenter: Michael A. Kutcher

March 28, 2019

Presentation JIM 2019

Iatrogenic aortocoronary dissection after routine PCI

Presenter: Pamela Gatto

February 15, 2019

Presentation Cardiovascular Interventions 2018

DAPT in Evolution: 2018

Presenter: Dean J. Kereiakes

October 26, 2018

Presentation TCT Abstracts Posters 2018

Outcomes of Preoperative Bridging with Intravenous Antiplatelet Therapy in Patients Undergoing Cardiac or Non-Cardiac Surgery Following Percutaneous Coronary Intervention

Presenter: Bassel Bou Dargham

September 25, 2018

Presentation TCT 2018

Case #5: A Case in Which I Used OCT to Reduce DAPT Duration

Presenter: David Erlinge, Gary S. Mintz, Martin W. Bergmann, Marc D. Feldman, Margaret B. McEntegart, Yasunori Ueda, Carlo Zivelonghi, Robert-Jan van Geuns

September 24, 2018

Presentation TCT 2018

EVOLVE SHORT-DAPT: Three-Month Outcomes on Dual Antiplatelet Therapy in a High Bleeding Risk Population Treated With a Bioresorbable Polymer-Based Drug-Eluting Stent

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Ajay J. Kirtane

September 24, 2018

Presentation TCT 2018

The Asian Anti-Platelet Therapy Paradox: Genetic Factors, Dosing, Bleeding, and Stent Thrombosis Risk

Presenter: Dominick J. Angiolillo, Elmir Omerovic, Duk-Woo Park

September 23, 2018

Presentation TCT 2018

De-Escalation of DAPT After DES Placement: Is There a Role for Personalized Treatment?

Presenter: Dominick J. Angiolillo, Elmir Omerovic, Dániel Aradi

September 23, 2018

Presentation TCT 2018

GLOBAL LEADERS in Perspective: Perspectives on Ticagrelor Monotherapy

Presenter: Dominick J. Angiolillo, Elmir Omerovic, Patrick W. Serruys

September 23, 2018

Presentation TCT 2018

Managing Aspirin Allergy Before DES Placement

Presenter: Dominick J. Angiolillo, Elmir Omerovic, John A. Bittl

September 23, 2018

Presentation TCT 2018

Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation

Presenter: Davide Capodanno, Giulio Stefanini, Robert A. Byrne

September 23, 2018

Presentation TCT 2018

US and ESC Guidelines and Consensus on Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing PCI

Presenter: Davide Capodanno, Giulio Stefanini, Dominick J. Angiolillo

September 23, 2018

Presentation TCT 2018

In 2018 When Is Warfarin Therapy Required vs Acceptable, and How Should it Be Dosed After PCI?

Presenter: Davide Capodanno, Giulio Stefanini, Freek W.A. Verheugt

September 23, 2018

Presentation TCT 2018

Has PIONEER and REDUAL Changed My Practice? What Are the Outstanding Issues?

Presenter: Davide Capodanno, Giulio Stefanini, C. Michael Gibson

September 23, 2018

Advertisement

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

Update: Drug-Eluting Stents

Update on Dual Antiplatelet Therapy

LAA Closure Patient Selection, Imaging and Anti-Thrombotic Therapy

Practical Considerations for Long DAPT Based on Lesion and Patient Selections

Pharmacologic Strategies for Managing Patients with Atrial Fibrillation Undergoing Coronary Intervention

DAPT Duration and When to Switch to Antiplatelet Monotherapy Post PCI

Iatrogenic aortocoronary dissection after routine PCI

DAPT in Evolution: 2018

Outcomes of Preoperative Bridging with Intravenous Antiplatelet Therapy in Patients Undergoing Cardiac or Non-Cardiac Surgery Following Percutaneous Coronary Intervention

Case #5: A Case in Which I Used OCT to Reduce DAPT Duration

EVOLVE SHORT-DAPT: Three-Month Outcomes on Dual Antiplatelet Therapy in a High Bleeding Risk Population Treated With a Bioresorbable Polymer-Based Drug-Eluting Stent

The Asian Anti-Platelet Therapy Paradox: Genetic Factors, Dosing, Bleeding, and Stent Thrombosis Risk

De-Escalation of DAPT After DES Placement: Is There a Role for Personalized Treatment?

GLOBAL LEADERS in Perspective: Perspectives on Ticagrelor Monotherapy

Managing Aspirin Allergy Before DES Placement

Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation

US and ESC Guidelines and Consensus on Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing PCI

In 2018 When Is Warfarin Therapy Required vs Acceptable, and How Should it Be Dosed After PCI?

Has PIONEER and REDUAL Changed My Practice? What Are the Outstanding Issues?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content